自己注射の世界市場レポート 2025年

自己注射の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.2％で141億3,000万米ドルに成長します。予測期間の成長は、パンデミックの影響と遠隔治療、新興市場への拡大、患者中心のヘルスケア、ドラッグデリバリーの優位性、個別化医療の動向に起因すると考えられます。予測期間の主な動向には、スマート技術の統合、生物製剤使用の増加、小型化とウェアラブルデバイス、安全機能の強化、自動注射器の採用などがあります。

糖尿病患者の増加は、今後の自己注射市場の成長を牽引すると予測されます。糖尿病は、インスリンを生成する臓器である膵臓がインスリンの生成量が不足し、血糖の分解を引き起こし、心臓病、視力低下、腎臓病などの重篤な健康状態を引き起こす疾患です。自己注射は、糖尿病患者自身がインスリンやその他の薬を投与することを可能にし、医療専門家の支援を必要とせずに血糖値を調整し、過剰な糖分の摂取を防ぐのに役立ちます。例えば、ベルギーを拠点に糖尿病の有病率、治療、ケアに関する包括的なデータを提供する世界の情報源であるIDF Diabetes Atlasによると、世界の糖尿病患者数は2030年の6億4,300万人から2045年には7億8,300万人と1億4,000万人増加すると予想されています。現在、5億3,700万人の成人が糖尿病を患っており、その75％以上が低・中所得国に居住しています。したがって、糖尿病患者の増加は自己注射市場の拡大に大きく寄与しています。

テレヘルスと遠隔医療の台頭が、今後の自己注射市場の成長を牽引すると予想されます。テレヘルスは通信技術を利用して遠隔地から幅広いヘルスケアサービスや情報を提供するものであり、遠隔医療は特に遠隔地からの臨床診察やヘルスケア提供に焦点を当てたものです。これらのデジタルヘルスプラットフォームはバーチャル診察を可能にし、医療提供者が遠隔地から自己注射薬を処方することを可能にします。患者はまた、自己注射を正しく投与するためのバーチャルトレーニングセッションの恩恵を受けることができます。さらにテレヘルスは、患者の服薬アドヒアランスのリアルタイムモニタリング、継続的な疾病管理、投薬のための遠隔薬局サービスへの容易なアクセスを容易にします。特にパンデミック時のテレヘルスの利便性は、患者の関与を高め、専門医療への全体的なアクセスを改善し、自己注射市場の成長に大きく寄与しています。例えば、米国政府の情報プロバイダーであるTelehealth.HHS.govによると、テレヘルスの利用者は2023年第4四半期に約2,188万3,731人に達し、前四半期に比べ278万3,159人（13％）増加しました。このように、テレヘルスと遠隔医療の増加が自己注射市場の拡大を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の自己注射市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の自己注射市場：成長率分析
• 世界の自己注射市場の実績：規模と成長、2019～2024年
• 世界の自己注射市場の予測：規模と成長、2024～2029年、2034年
• 世界の自己注射総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の自己注射市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• デバイス
• 製剤
• 世界の自己注射市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 皮膚
• 循環器系または筋骨格系
• 循環器系
• 中枢神経系
• 世界の自己注射市場：投与量別、実績と予測、2019～2024年、2024～2029年、2034年
• 単回投与
• 複数回投与
• 世界の自己注射市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 自己免疫疾患
• ホルモン疾患
• 腫瘍学
• 希少疾患
• 疼痛管理
• 呼吸療法
• その他
• 世界の自己注射市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• クリニック
• 薬局
• オンライン薬局
• 世界の自己注射市場：デバイスのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• プレフィルドシリンジ
• 自動注射器
• マイクロニードルデバイス
• ウェアラブル注射器
• 世界の自己注射市場：製剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 生物製剤
• ワクチン
• 低分子
• 組み合わせ製品

第7章 地域別・国別分析

• 世界の自己注射市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の自己注射市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 自己注射市場：競合情勢
• 自己注射市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Antares Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bristol-Myers Squibb Company
• Credence MedSystems Inc.
• Dali Medical Devices Ltd.
• Eli Lilly and Company
• Enable Injections Inc.
• Gerresheimer AG
• Insulet Corporation
• Merck & Co. Inc.
• Owen Mumford Limited
• Pfizer Inc.
• PharmaJet Inc.
• Recipharm AB
• Schott AG
• SHL Group Limited
• Terumo Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 自己注射市場2029年：新たな機会を提供する国
• 自己注射市場2029年：新たな機会を提供するセグメント
• 自己注射市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Self-injection refers to the act of administering medications or drugs through a device by an individual to themselves without the assistance of a medical professional. This practice allows patients to independently manage their medication regimen.

The primary types of self-injections encompass devices and formulations. These devices enable patients to self-administer medications that require injection without relying on medical professionals. Self-injection devices are utilized for various routes of administration such as skin, circulatory or musculoskeletal systems, organs, and the central nervous system. Dosage types include single-dose and multi-dose, catering to applications in autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, among others. These devices are distributed through various channels including hospitals, pharmacies, clinics, chemists, and online pharmacies.

The self injections market research report is one of a series of new reports from The Business Research Company that provides self injections market statistics, including self injections industry global market size, regional shares, competitors with a self injections market share, detailed self injections market segments, market trends and opportunities, and any further data you may need to thrive in the self injections industry. This self injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The self-injections market size has grown strongly in recent years. It will grow from $9.69 billion in 2024 to $10.3 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rising chronic diseases, improved patient empowerment, regulatory support, preference for home healthcare, cost-effectiveness.

The self-injections market size is expected to see strong growth in the next few years. It will grow to $14.13 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to pandemic impact and remote treatment, expansion into emerging markets, patient-centric healthcare, advantages in drug delivery, personalized medicine trends. Major trends in the forecast period include smart technology integration, rise in biologics usage, miniaturization and wearable devices, enhanced safety features, adoption of autoinjectors.

The increasing number of diabetic patients is anticipated to drive the growth of the self-injections market in the future. Diabetes is a condition where the pancreas, an organ responsible for producing insulin, generates an insufficient amount of insulin, leading to the breakdown of blood sugar and resulting in severe health conditions such as heart disease, vision loss, and kidney disease. Self-injections allow diabetic patients to administer insulin and other medications themselves, helping to regulate blood sugar levels and prevent excess sugar without the need for assistance from a medical professional. For example, according to the IDF Diabetes Atlas, a Belgium-based global resource offering comprehensive data on diabetes prevalence, treatment, and care, the global number of diabetes cases is expected to rise from 643 million in 2030 to 783 million by 2045, an increase of 140 million cases. Currently, 537 million adults live with diabetes, with more than 75% residing in low- and middle-income countries. Therefore, the growing number of diabetic patients is significantly contributing to the expansion of the self-injections market.

The rise of telehealth and telemedicine is expected to drive the growth of the self-injections market in the future. Telehealth involves the use of telecommunications technology to deliver a wide range of healthcare services and information remotely, while telemedicine focuses specifically on remote clinical consultations and healthcare delivery. These digital health platforms enable virtual consultations, allowing healthcare providers to prescribe self-injectable medications from a distance. Patients also benefit from virtual training sessions that ensure they administer self-injections correctly. Additionally, telehealth facilitates real-time monitoring of patient adherence, ongoing disease management, and easy access to telepharmacy services for medication delivery. The convenience of telehealth, especially during pandemics, enhances patient engagement and improves overall access to specialized care, significantly contributing to the growth of the self-injections market. For example, according to Telehealth.HHS.gov, a U.S. government information provider, telehealth usage reached approximately 21,883,731 users in Q4 2023, marking an increase of 2,783,159 users, or 13%, compared to the previous quarter. Thus, the increase in telehealth and telemedicine is driving the expansion of the self-injections market.

Innovation in insulin injection solutions is a key trend in the self-injections market, with major companies focusing on developing new products to gain a competitive edge. For example, in September 2022, Terumo Corporation, a Japan-based medical device company, launched FineGlide, a sterile pen needle designed for patients requiring regular insulin injections or other self-medication. FineGlide prioritizes patient comfort by featuring a 3-bevel super sharp needle with a high-grade silicone surface, ensuring gentleness during injections. The inclusion of Thin Wall Technology improves flow rate and reduces injection force, enhancing the overall experience for patients and promoting drug compliance. This focus on product innovation demonstrates the commitment of major companies to meet the evolving needs of patients in the self-injections market.

Major players in the self-injections market are focusing on the development of smart injecting devices to gain a competitive advantage. In March 2022, Pfizer Inc., a prominent US-based pharmaceutical company, introduced ENBREL SmartClic in Australia. This innovative self-injecting device is designed for patients undergoing treatment with ENBREL, a tumor necrosis factor (TNF) inhibitor prescribed for conditions like Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), and Psoriatic Arthritis (PsA). ENBREL SmartClic features an automated, reusable design with user-friendly elements, including a one-button initiation, a larger grip compared to the Enbrel Auto-Injector, and injection speed control. The device is accompanied by a smartphone app, providing additional features such as reminders, injection history recording, site tracking, and streamlined reports. Patients can access these features on their smartphones and share the information with healthcare professionals, enhancing the overall self-injection experience for those dealing with chronic inflammatory diseases.

In June 2022, Dr. Reddy Labs, an India-based pharmaceutical manufacturer, made a significant acquisition by purchasing an injectable portfolio from Eton Pharma for $50 million. This strategic move by Dr. Reddy's aimed to accelerate and expand the availability of affordable medications for patients. The acquisition included new portfolios such as injections and recipes, allowing Dr. Reddy's to diversify its product offerings and strengthen its position in the pharmaceutical market. Eton Pharma, a US-based pharmaceutical manufacturer, contributed to Dr. Reddy's efforts to broaden its pharmaceutical portfolio, signaling a strategic expansion into injectable medications.

Major companies operating in the self-injections market are AbbVie Inc., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Company, Bristol-Myers Squibb Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Merck & Co. Inc., Owen Mumford Limited, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, SHL Group Limited, Terumo Corporation, West Pharmaceutical Services Inc., Wilhelm Haselmeier GmbH & Co. KG, Ypsomed Holding AG, APTAR PHARMA INDIA PVT LTD, Bespak Europe Ltd., Bioject Medical Technologies Inc., Catalent Inc., Crossject SA, Injex Pharma AG, Medeca Pharma AB, Medimop Medical Projects Ltd., Mylan N.V., Nemera Development S.A., Noble Medical Inc.

North America was the largest region in the self injections market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-injections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the self-injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The self injections market consists of sales of auto-injectors, needle-free injectors, pen injectors and wearable injectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Self-Injections Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on self-injections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for self-injections ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The self-injections market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Devices; Formulations
• 2) By Route Of Administration: Skin; Circulatory Or Musculoskeletal; Organs; Central Nervous System
• 3) By Dosage: Single Dose; Multi Dose
• 4) By Application: Autoimmune Diseases; Hormonal Disorders; Oncology; Orphan Diseases; Pain Management; Respiratory Therapy; Other Applications
• 5) By Distribution Channel: Hospitals Pharmacies; Clinics; Chemist; Online Pharmacies
• Subsegments:
• 1) By Devices: Pre-Filled Syringes; Auto-Injectors; Microneedle Devices; Wearable Injectors
• 2) By Formulations: Biologics; Vaccines; Small Molecules; Combination Products
• Companies Mentioned: AbbVie Inc.; Antares Pharma Inc.; Baxter International Inc.; Bayer AG; Becton Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Self-Injections Market Characteristics

3. Self-Injections Market Trends And Strategies

4. Self-Injections Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Self-Injections Growth Analysis And Strategic Analysis Framework

• 5.1. Global Self-Injections PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Self-Injections Market Growth Rate Analysis
• 5.4. Global Self-Injections Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Self-Injections Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Self-Injections Total Addressable Market (TAM)

6. Self-Injections Market Segmentation

• 6.1. Global Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Devices
• Formulations
• 6.2. Global Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Skin
• Circulatory Or Musculoskeletal
• Organs
• Central Nervous System
• 6.3. Global Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Dose
• Multi Dose
• 6.4. Global Self-Injections Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autoimmune Diseases
• Hormonal Disorders
• Oncology
• Orphan Diseases
• Pain Management
• Respiratory Therapy
• Other Applications
• 6.5. Global Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals Pharmacies
• Clinics
• Chemist
• Online Pharmacies
• 6.6. Global Self-Injections Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-Filled Syringes
• Auto-Injectors
• Microneedle Devices
• Wearable Injectors
• 6.7. Global Self-Injections Market, Sub-Segmentation Of Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologics
• Vaccines
• Small Molecules
• Combination Products

7. Self-Injections Market Regional And Country Analysis

• 7.1. Global Self-Injections Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Self-Injections Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Self-Injections Market

• 8.1. Asia-Pacific Self-Injections Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Self-Injections Market

• 9.1. China Self-Injections Market Overview
• 9.2. China Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Self-Injections Market

• 10.1. India Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Self-Injections Market

• 11.1. Japan Self-Injections Market Overview
• 11.2. Japan Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Self-Injections Market

• 12.1. Australia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Self-Injections Market

• 13.1. Indonesia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Self-Injections Market

• 14.1. South Korea Self-Injections Market Overview
• 14.2. South Korea Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Self-Injections Market

• 15.1. Western Europe Self-Injections Market Overview
• 15.2. Western Europe Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Self-Injections Market

• 16.1. UK Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Self-Injections Market

• 17.1. Germany Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Self-Injections Market

• 18.1. France Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Self-Injections Market

• 19.1. Italy Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Self-Injections Market

• 20.1. Spain Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Self-Injections Market

• 21.1. Eastern Europe Self-Injections Market Overview
• 21.2. Eastern Europe Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Self-Injections Market

• 22.1. Russia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Self-Injections Market

• 23.1. North America Self-Injections Market Overview
• 23.2. North America Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Self-Injections Market

• 24.1. USA Self-Injections Market Overview
• 24.2. USA Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Self-Injections Market

• 25.1. Canada Self-Injections Market Overview
• 25.2. Canada Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Self-Injections Market

• 26.1. South America Self-Injections Market Overview
• 26.2. South America Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Self-Injections Market

• 27.1. Brazil Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Self-Injections Market

• 28.1. Middle East Self-Injections Market Overview
• 28.2. Middle East Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Self-Injections Market

• 29.1. Africa Self-Injections Market Overview
• 29.2. Africa Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Self-Injections Market Competitive Landscape And Company Profiles

• 30.1. Self-Injections Market Competitive Landscape
• 30.2. Self-Injections Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Antares Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Self-Injections Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb Company
• 31.2. Credence MedSystems Inc.
• 31.3. Dali Medical Devices Ltd.
• 31.4. Eli Lilly and Company
• 31.5. Enable Injections Inc.
• 31.6. Gerresheimer AG
• 31.7. Insulet Corporation
• 31.8. Merck & Co. Inc.
• 31.9. Owen Mumford Limited
• 31.10. Pfizer Inc.
• 31.11. PharmaJet Inc.
• 31.12. Recipharm AB
• 31.13. Schott AG
• 31.14. SHL Group Limited
• 31.15. Terumo Corporation

32. Global Self-Injections Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Self-Injections Market

34. Recent Developments In The Self-Injections Market

35. Self-Injections Market High Potential Countries, Segments and Strategies

• 35.1 Self-Injections Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Self-Injections Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Self-Injections Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer